| 000 | 00856 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516212320.0 | ||
| 264 | 0 | _c20140821 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.113.002695 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonnan, Geoffrey A | |
| 245 | 0 | 0 |
_aNewer anticoagulants should not be used for off-label indications. _h[electronic resource] |
| 260 |
_bStroke _cJul 2014 |
||
| 300 |
_a2156-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOff-Label Use _xstandards |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 773 | 0 |
_tStroke _gvol. 45 _gno. 7 _gp. 2156-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.113.002695 _zAvailable from publisher's website |
| 999 |
_c23809546 _d23809546 |
||